Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/224160


Analgesics in Israel


Description: The Analgesics in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?
- Get a detailed picture of the analgesics industry
- Pinpoint growth sectors and trends and identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop

.


Contents: Analgesics in Israel
Euromonitor International
May 2009
List of Contents and Tables
Executive Summary
2008 Continues Positive Growth Rates Similar To the Review Period
Demand for More Specific Treatments Leads To New Innovations and Launches
Private Label Benefits From Unique Market Structure
Gsl Revolution Did Not Bring Expected Results
Economic Slowdown Aside, Some Sectors Are Expected To See Strong Growth
Key Trends and Developments
Unusual Market Structure With OTC Drugs Falling in the "health Basket"
Increased Private Label Activity
Specific Drugs Answer Consumer Demand for Specification
Gsl Revolution Failed To Impact the Retail Market As Expected
Economic Slowdown Is Expected Only in 2009
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventive Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
Definitions
Summary 2 Research Sources
Dexxon Ltd
Strategic Direction
Key Facts
Summary 3 Dexxon Ltd: Key Facts
Summary 4 Dexxon Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Dexxon Ltd: Competitive Position 2008
New-pharm Drugstores Ltd
Strategic Direction
Key Facts
Summary 6 New-Pharm Drugstores Ltd: Key Facts
Summary 7 New-Pharm Drugstores Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Rekah Pharmaceutical Products Ltd
Strategic Direction
Key Facts
Summary 8 Rekah Pharmaceutical Products Ltd: Key Facts
Summary 9 Rekah Pharmaceutical Products Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Rekah Pharmaceutical Products Ltd: Competitive Position 2008
Super-pharm (israel) Ltd
Strategic Direction
Key Facts
Summary 11 Super Pharm Israel Ltd: Key Facts
Summary 12 Super Pharm Israel Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Teva Pharmaceutical Industries Ltd
Strategic Direction
Key Facts
Summary 13 Teva Pharmaceutical Industries Ltd: Key Facts
Summary 14 Teva Pharmaceutical Industries Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Teva Pharmaceutical Industries Ltd: Competitive Position 2008
Trima Israel Pharmaceutical Products Maabarot Ltd
Strategic Direction
Key Facts
Summary 16 Trima Israel Pharmaceutical Products Maabarot Ltd: Key Facts
Summary 17 Trima Israel Pharmaceutical Products Maabarot Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 18 Trima Israel Pharmaceutical Products Maabarot Ltd Competitive Position 2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013


Summary: CH06anIS




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/224160

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 28/11/2009 10:47:45
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Analgesics in Israel
Web Address:
http://www.researchandmarkets.com/reports/224160
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €675.00
Electronic (PDF) - Site License €1,350.00
Electronic (PDF) - Enterprisewide €2,025.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 28/11/2009 10:47:45

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)